178 related articles for article (PubMed ID: 32641586)
1. Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes.
Vieira CP; Fortmann SD; Hossain M; Longhini AL; Hammer SS; Asare-Bediako B; Crossman DK; Sielski MS; Adu-Agyeiwaah Y; Dupont M; Floyd JL; Li Calzi S; Lydic T; Welner RS; Blanchard GJ; Busik JV; Grant MB
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641586
[TBL] [Abstract][Full Text] [Related]
2. Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol.
Pfeifer T; Buchebner M; Chandak PG; Patankar J; Kratzer A; Obrowsky S; Rechberger GN; Kadam RS; Kompella UB; Kostner GM; Kratky D; Levak-Frank S
Curr Pharm Biotechnol; 2011 Feb; 12(2):285-92. PubMed ID: 21190543
[TBL] [Abstract][Full Text] [Related]
3. Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.
Quinet EM; Savio DA; Halpern AR; Chen L; Miller CP; Nambi P
J Lipid Res; 2004 Oct; 45(10):1929-42. PubMed ID: 15292374
[TBL] [Abstract][Full Text] [Related]
4. Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice.
Patel M; Wang XX; Magomedova L; John R; Rasheed A; Santamaria H; Wang W; Tsai R; Qiu L; Orellana A; Advani A; Levi M; Cummins CL
Diabetologia; 2014 Feb; 57(2):435-46. PubMed ID: 24201575
[TBL] [Abstract][Full Text] [Related]
5.
El-Darzi N; Astafev A; Mast N; Saadane A; Lam M; Pikuleva IA
Front Pharmacol; 2018; 9():827. PubMed ID: 30090064
[No Abstract] [Full Text] [Related]
6. Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction.
Hammer SS; Vieira CP; McFarland D; Sandler M; Levitsky Y; Dorweiler TF; Lydic TA; Asare-Bediako B; Adu-Agyeiwaah Y; Sielski MS; Dupont M; Longhini AL; Li Calzi S; Chakraborty D; Seigel GM; Proshlyakov DA; Grant MB; Busik JV
Diabetologia; 2021 Jul; 64(7):1674-1689. PubMed ID: 33770194
[TBL] [Abstract][Full Text] [Related]
7. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
[TBL] [Abstract][Full Text] [Related]
8. Enhanced endoplasmic reticulum stress in bone marrow angiogenic progenitor cells in a mouse model of long-term experimental type 2 diabetes.
Bhatta M; Ma JH; Wang JJ; Sakowski J; Zhang SX
Diabetologia; 2015 Sep; 58(9):2181-90. PubMed ID: 26063198
[TBL] [Abstract][Full Text] [Related]
9. In search for novel liver X receptors modulators by extending the structure-activity relationships of cholenamide derivatives.
Pontini L; Palazzoli P; Maggioni D; Damiano G; Giorgi G; Russo V; Marinozzi M
Chem Phys Lipids; 2021 Nov; 241():105151. PubMed ID: 34673009
[TBL] [Abstract][Full Text] [Related]
10. Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy.
Chakravarthy H; Navitskaya S; O'Reilly S; Gallimore J; Mize H; Beli E; Wang Q; Kady N; Huang C; Blanchard GJ; Grant MB; Busik JV
Stem Cells; 2016 Apr; 34(4):972-83. PubMed ID: 26676316
[TBL] [Abstract][Full Text] [Related]
11. The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X Receptor.
Hammer SS; Beli E; Kady N; Wang Q; Wood K; Lydic TA; Malek G; Saban DR; Wang XX; Hazra S; Levi M; Busik JV; Grant MB
EBioMedicine; 2017 Aug; 22():181-190. PubMed ID: 28774737
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and activity evaluation of a series of cholanamides as modulators of the liver X receptors.
Martínez MD; Ghini AA; Dansey MV; Veleiro AS; Pecci A; Alvarez LD; Burton G
Bioorg Med Chem; 2018 Mar; 26(5):1092-1101. PubMed ID: 29428525
[TBL] [Abstract][Full Text] [Related]
13. Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy.
Chakravarthy H; Beli E; Navitskaya S; O'Reilly S; Wang Q; Kady N; Huang C; Grant MB; Busik JV
PLoS One; 2016; 11(1):e0146829. PubMed ID: 26760976
[TBL] [Abstract][Full Text] [Related]
14. N,N-Dimethyl-3β-hydroxycholenamide attenuates neuronal death and retinal inflammation in retinal ischemia/reperfusion injury by inhibiting Ninjurin 1.
Shi Y; Liu Y; Wu C; Liu X; Hu W; Yang Z; Li Z; Li Y; Deng C; Wei K; Gu C; Chen X; Su W; Zhuo Y
J Neuroinflammation; 2023 Apr; 20(1):91. PubMed ID: 37029422
[TBL] [Abstract][Full Text] [Related]
15. Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver.
Tagawa H; Irie J; Itoh A; Kusumoto Y; Kato M; Kobayashi N; Tanaka K; Morinaga R; Fujita M; Nakajima Y; Morimoto K; Sugizaki T; Kawano Y; Yamada S; Kawai T; Watanabe M; Itoh H
Diabetes Res Clin Pract; 2015 Jul; 109(1):85-94. PubMed ID: 25981325
[TBL] [Abstract][Full Text] [Related]
16. Reduction of fibrosis and immune suppressive cells in ErbB2-dependent tumorigenesis by an LXR agonist.
Sheng G; Yuan H; Jin L; Ranjit S; Panov J; Lu X; Levi M; Glazer RI
PLoS One; 2021; 16(3):e0248996. PubMed ID: 33780491
[TBL] [Abstract][Full Text] [Related]
17. Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1-Mediated Cholesterol Removal.
Saadane A; Mast N; Trichonas G; Chakraborty D; Hammer S; Busik JV; Grant MB; Pikuleva IA
Am J Pathol; 2019 Feb; 189(2):405-425. PubMed ID: 30448403
[TBL] [Abstract][Full Text] [Related]
18. Reversal of Bone Marrow Mobilopathy and Enhanced Vascular Repair by Angiotensin-(1-7) in Diabetes.
Vasam G; Joshi S; Thatcher SE; Bartelmez SH; Cassis LA; Jarajapu YP
Diabetes; 2017 Feb; 66(2):505-518. PubMed ID: 27856608
[TBL] [Abstract][Full Text] [Related]
19. Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells.
Barthelmes D; Irhimeh MR; Gillies MC; Karimipour M; Zhou M; Zhu L; Shen WY
Blood Cells Mol Dis; 2013 Oct; 51(3):163-73. PubMed ID: 23714230
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice.
He Q; Pu J; Yuan A; Yao T; Ying X; Zhao Y; Xu L; Tong H; He B
Cardiovasc Diabetol; 2014 Nov; 13():149. PubMed ID: 25416469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
